US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 32.040
  • -0.170-0.53%
Close Apr 26 16:00 ET
  • 32.040
  • 0.0000.00%
Post 17:32 ET
1.19BMarket Cap-6935P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Tarsus Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 27, 2024

Revenue(YoY)

13.08M

+30.76%
EPS(YoY)

-1.31

-167.35%

Strong Buy

Mar 31, 2024

Tarsus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 22.848M--
--2024/Q1-- / 17.898M--
Feb 27, 20242023/Q413.076M / 5.924M--
Nov 9, 20232023/Q31.871M / 361.000K--
--2023/Q20.000 / 0.000--
--2023/Q12.500M / 3.333M--
--2022/Q410.000M / 10.000M--
--2022/Q30.000 / 3.500M--
--2022/Q215.277M / 11.250M--
--2022/Q1539.000K / 2.200M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 22.848M--
--2024/Q1-- / 17.898M--
Feb 27, 20242023/Q413.076M / 5.924M--
Nov 9, 20232023/Q31.871M / 361.000K--
--2023/Q20.000 / 0.000--
--2023/Q12.500M / 3.333M--
--2022/Q410.000M / 10.000M--
--2022/Q30.000 / 3.500M--
--2022/Q215.277M / 11.250M--
--2022/Q1539.000K / 2.200M--

Unlock Free Earnings Estimates

Tarsus Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Strong Buy

  • Buy

    85.71%
  • Hold

    14.29%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg